Equities

Enablence Technologies Inc

ENA:CVE

Enablence Technologies Inc

Actions
  • Price (CAD)1.40
  • Today's Change0.00 / 0.00%
  • Shares traded4.00k
  • 1 Year change0.00%
  • Beta1.4338
Data delayed at least 15 minutes, as of May 24 2024 14:54 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Enablence Technologies Inc. is a Canada-based company that designs, manufactures and sells optical components, primarily in the form of planar lightwave circuits (PLC), on silicon-based chips. The Company's products serve a global customer base, primarily focused on data center and other end markets. It also works with customers that have emerging market uses for its technology, including medical devices, automotive light detection and ranging (LiDAR) and virtual and augmented reality headsets. The Company also uses a non-captive fabrication plant in Fremont, California to manufacture chips designed by third party customers. The Company's products include coarse wavelength division multiplexing, dense wavelength division multiplexing, LAN-wavelength division multiplexing, ultra-long delay lines, custom fab services and custom design services. Its technology includes advanced signal processing, artificial intelligence and machine learning chip design and coherent optics, among others.

  • Revenue in CAD (TTM)2.13m
  • Net income in CAD-14.88m
  • Incorporated2006
  • Employees202.00
  • Location
    Enablence Technologies Inc390 March Rd Suite 119KANATA K2K 0G7CanadaCAN
  • Phone+1 (613) 656-2850
  • Fax+1 (613) 656-2855
  • Websitehttps://www.enablence.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Hapbee Technologies Inc1.31m-3.72m13.27m--------10.16-0.0525-0.05250.0167-0.02720.37272.657.52---106.18---1,124.43--41.98---284.93--0.1167-------47.73--26.20------
Aurora Spine Corp21.38m-1.76m19.67m13.00--2.84--0.92-0.0245-0.02450.2940.08991.421.924.09---11.69-16.00-16.45-22.2358.8646.65-8.25-11.761.39-5.800.4195---2.4010.83-11.93--10.36--
Medx Health Corp456.09k-4.58m21.01m--------46.07-0.0242-0.02420.0023-0.02730.64790.758257.37---650.72-653.82----40.7049.55-1,004.31-736.740.0384-1.40-----10.68-15.9510.77------
NuGen Medical Devices Inc331.41k-9.36m21.40m--------64.57-0.0572-0.05720.002-0.0104----------------49.74---2,824.97--0.3405-5.961.35--117.51---67.84------
Enablence Technologies Inc2.13m-14.88m26.41m202.00------12.41-0.8003-0.80030.1145-1.300.69857.639.45---488.37-191.45-----119.94-61.64-699.16-250.290.2346-3.46-----0.8595-10.36-173.59--5.99--
VentriPoint Diagnostics Ltd.49.18k-4.87m35.46m----186.00--721.01-0.0311-0.03110.00030.00120.0125--2.26---123.97-105.23-180.19-178.0186.2767.16-9,906.34-8,020.43---817.660.6850---27.86-3.960.0177------
Theralase Technologies Inc1.07m-4.57m35.80m0.00--19.18--33.45-0.0209-0.02090.00490.00830.28780.88863.45---122.91-69.79-160.98-81.7852.5237.49-427.06-557.680.7803--0.1688---6.00-9.2012.69---22.53--
Perimeter Medical Imaging AI Inc537.68k-17.71m35.87m----2.05--66.72-0.2739-0.27390.00830.26790.01682.885.06---55.33-67.97-70.91-85.3147.47---3,293.39-7,492.494.03--0.0139--295.60---84.43------
Data as of May 24 2024. Currency figures normalised to Enablence Technologies Inc's reporting currency: Canadian Dollar CAD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.